Trials / Completed
CompletedNCT03889145
A Study to Evaluate the Drug-drug Interaction Between Telmisartan, Amlodipine and Hydrochlorothiazide
A Randomized, Open-label, Single Dose, 3-way Crossover Study to Evaluate the Drug-drugs Interaction Between Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- IlDong Pharmaceutical Co Ltd · Industry
- Sex
- Male
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A randomized, open-label, single dose, 3-way crossover study to evaluate the drug-drugs interaction between Telmisartan, Amlodipine and Hydrochlorothiazide in healthy male volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Telmisartan 80mg | Telmisartan 80mg |
| DRUG | Amlodipine10mg | Amlodipine 10mg |
| DRUG | Hydrochlorothiazide | Hydrochlorothiazide 25mg |
Timeline
- Start date
- 2013-12-19
- Primary completion
- 2014-02-19
- Completion
- 2014-02-19
- First posted
- 2019-03-26
- Last updated
- 2019-03-26
Source: ClinicalTrials.gov record NCT03889145. Inclusion in this directory is not an endorsement.